Aclaris Therapeutics Inc (FRA:8AT)
€ 1.0195 -0.004 (-0.39%) Market Cap: 74.98 Mil Enterprise Value: -35.52 Mil PE Ratio: 0 PB Ratio: 0.57 GF Score: 48/100

Aclaris Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 04, 2020 / 01:00PM GMT
Release Date Price: €1.26 (-1.56%)
Operator

Hello, everyone, and welcome to the 2020 Annual Meeting of Stockholders for Aclaris Therapeutics, Inc. My name is Andrew, and I will be your operator today. Please note that today's meeting is being recorded for webcast.

I would now like to introduce Dr. Neal Walker, President and Chief Executive Officer of Aclaris Therapeutics, Inc.

Neal S. Walker
Aclaris Therapeutics, Inc. - Co-Founder, CEO, President & Director

Good morning. I'm Neal Walker, and I am the President and Chief Executive Officer and a member of the Board of Directors of Aclaris Therapeutics. I'm very happy to welcome you to the Aclaris 2020 Annual Stockholders Meeting. We are holding the annual meeting virtually this year instead of in-person as a result of heightened health and safety concerns due to the ongoing COVID-19 pandemic.

Before I call the meeting to order, I'd like to introduce you to the members of the Board and the business team who are with us today. The other members of the Board with us today are Chris Molineaux, Maxine Gowen, Vin Milano, Andrew Powell,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot